Navigation Links
Combining CT, FDG-PET provides more accurate treatments for head and neck cancer patients
Date:4/29/2011

Combining computerized tomography (CT) with fluorodeoxyglucose positron emission tomography (FDG-PET) images results in significantly more defined tumor outlines and potentially different treatment options in head and neck cancer patients compared to using CT alone, according to research presented today, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. This symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).

CT is the standard method for determining tumor delineation before deciding head and neck cancer treatmenttypically intensity modulated radiation therapy. However, FDG-PET is an imaging method that uses a radioactive product combined with sugar and can produce better defined outlines of the tumor.

Researchers sought to determine the significance of combining CT and FDG-PET when determining tumor delineation and treatment for head and neck cancer patients.

In this trial, 327 patients were treated with IMRT for head and neck cancer. Based on the combined approach of the CT-scan and FDG-PET, the researchers noticed a change in the delineation of the tumor in one out of three patients, resulting in 10 percent of patients' treatment being changed and 33 percent of patients having their treatment adjusted.

In 17 percent of the patients, the primary tumor was not visible on the CT-scan alone, mostly due to dental inlays.

"We expected there to be an improved delineation of the tumor," Homan Dehnad, MD, a study author and radiation oncologist at Utrecht University Medical Center in Utrecht, Netherlands, said. "However, we never expected it to have such an influence on the treatment options for patients. Each dedicated institute dealing with head and neck cancer should be equipped with multi-imaged facilities."


'/>"/>

Contact: Beth Bukata
bethb@astro.org
American Society for Radiation Oncology
Source:Eurekalert

Page: 1

Related medicine news :

1. Combining MEK and PI3K inhibitors appears encouraging in a safety study with early signs of anti-tumor activity
2. Combining 2 peptide inhibitors might block tumor growth
3. Visual prostheses: Symposium to explore combining functional endpoints
4. Study provides molecular rationale for combining targeted agents to treat breast cancer
5. Combining radiation therapy, chemotherapy safely treats head and neck cancer patients
6. Combining medication and psychosocial treatments may benefit patients with early-stage schizophrenia
7. Combining resistance and endurance training best for heart health
8. FDG-PET/CT plays a definite role in detecting colorectal cancer recurrences
9. Teachers-based intervention provides stress resistance in war-exposed children
10. Discovery of 2 new genes provides hope for stemming Staph infections
11. Study provides first link between 2 major Parkinsons genes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: